You searched for Antibody candidate - Page 30 of 69

abbvie ablynx rheumatoid arthritis nanobody

News and Trends 11 Jul 2016

Nanobody Phase II Results for Arthritis: Good but not good enough?

…anti-IL-6R antibody. The candidate targets a receptor for interleukin-6, a protein involved in inflammation. Interleukin-6 is also the target for the rheumatoid arthritis candidates of Janssen’s sirukumab and Sanofi’s sarilumab….

July 11, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 26 Oct 2021

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

…shots currently on the market. Valneva’s vaccine candidate consists of a killed or ‘inactivated’ version of SARS-CoV-2, the virus responsible for Covid-19. The vaccine was tested in adults aged 18…

October 26, 2021 - 5 minutesmins - By Victor Kotsev

ablynx antibodies rsv infection nanobody llama

News and Trends 18 Dec 2015

64 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives

…year. ALX-0171 is a wholly-owned Nanobody drug candidate administered through inhalation (nebulisation), for the treatment of respiratory syncytial virus (RSV) infection in infants. The candidate is also a trivalent Nanobody…

December 18, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 17 Jan 2023

EverImmune launches trial for oncobiotic lung and kidney cancer drug candidate

…treatment. The patients are given a daily dose of Oncobax AK to see if the drug candidate can reverse this resistance. Currently, up to 70% of NSCLC patients and 60%…

January 17, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 31 Oct 2023

Six biotech companies in Melbourne that have been making the news

…Melbourne. Ena Respiratory Melbourne-based biotech company Ena Respiratory was awarded $4.38 million from the U.S. Department of Defense (DoD) to speed up the development of its lead drug candidate INNA-051,…

October 31, 2023 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 15 Dec 2022

EMA gives Myrtelle’s Canavan disease gene therapy candidate OD designation

…candidate for the treatment of Canavan disease (CD). EMA OD designation’s aim is to encourage the development of treatments for life-threatening rare conditions by providing incentives such as protocol assistance,…

December 15, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Feb 2018

Spring Cleaning: AstraZeneca Ditches Underperforming Asthma and Cancer Candidates

…active. The two previous studies looked at the candidate as a monotherapy, which doesn’t appear to have gone too well. The remaining trial is testing MEDI0680 in combination with another…

February 6, 2018 - 3 minutesmins - By Alex Dale

Best in Biotech 7 Nov 2024

Cystic fibrosis: Five biotechs breathing life into the therapeutic space

…of the drug helped clear mucus in the airway in sheep models. The drug candidate is currently in phase 2 studies, and the first person was dosed back in July….

November 7, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 22 Sep 2016

After only 6 months, Akarna seals the deal with Allergan for €44.8M upfront

…old company was offered a €44.8M upfront payment by Allergan. Now, the Irish giant owns all rights to Akarna’s lead candidate, AKN-083, in addition to several other candidates. AKN-083 is…

September 22, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

bioarctic alzheimers disease plaques amyloid beta neurons Edited

More News! 25 Mar 2019

Swedish Biotech’s Stock Severely Hit by Failure of Biogen’s Alzheimer’s Drug

…were scheduled to start a phase III trial of an antibody treatment for Alzheimer’s. Although the antibody is not the same as Biogen’s, both antibodies target pathological forms of a…

March 25, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 15 Jul 2016

UK Biotech buys Swiss Antibodies to accelerate CAR-T Development

…treatment of cancer. This is because Delenex’s antibody platform (PENTRA) allows rapid development of humanized antibody types, including single chain Fv fragments (scFv), IgG and bispecific antibodies. ‘PENTRA bodies‘ are…

July 15, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 1 Jul 2022

License submitted to FDA for drug to help those with large B-cell lymphoma

A biologics license application has been submitted to the US Food and Drug Administration (FDA) for an antibody to treat patients with B-cell lymphoma. Genmab A/S is a biotechnology company…

July 1, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Nanobody Phase II Results for Arthritis: Good but not good enough?

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

64 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives

EverImmune launches trial for oncobiotic lung and kidney cancer drug candidate

Six biotech companies in Melbourne that have been making the news

EMA gives Myrtelle’s Canavan disease gene therapy candidate OD designation

Spring Cleaning: AstraZeneca Ditches Underperforming Asthma and Cancer Candidates

Cystic fibrosis: Five biotechs breathing life into the therapeutic space

After only 6 months, Akarna seals the deal with Allergan for €44.8M upfront

Swedish Biotech’s Stock Severely Hit by Failure of Biogen’s Alzheimer’s Drug

UK Biotech buys Swiss Antibodies to accelerate CAR-T Development

License submitted to FDA for drug to help those with large B-cell lymphoma

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!